| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
7 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-02-18 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Receiving CE Mark approval of pre-assembled disposable kit for CompuFlo® Epidural
System in Europe
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that the new pre-assembled disposable kit for the CompuFlo® Epidural
System has received CE Mark approval in Europe through the Company’s supplier.
The Board of Directors of the Issuer believes that this CE Mark approval overcomes
an important hurdle to commercialization in Europe. Based on market feedback, it was
evident that anesthesiologists using the epidural instrument preferred to have the
disposable kit pre-assembled before packaging to save valuable minutes in the operatory.
Albeit a modest change, this modification required the Issuer to secure regulatory
approval in Europe, which the Company has now achieved.
|
|
|
RB_ASO: Receiving CE Mark approval of pre-assembled disposable kit for CompuFlo® Epidural
System in Europe
